Tandem Synthesis of Novel thiazole-substituted pyrrolo[1,2-d][1,2,4]triazin-4(3H)-one Derivatives and their Theoretical Pharmacokinetic Profiles

被引:2
作者
Kuzu, Eylem [1 ]
Kuzu, Burak [2 ]
机构
[1] Van Yuzuncu Yil Univ, Inst Nat & Appl Sci, Chem Sect, TR-65080 Van, Turkiye
[2] Van Yuzuncu Yil Univ, Fac Pharm, Pharmaceut Chem Sect, TR-65080 Van, Turkiye
关键词
pyrrolotriazinones; thiazole; ADMET profile; DFT; tandem synthesis; MEDICINAL CHEMISTRY; DRUG-LIKENESS; PYRROLES;
D O I
10.1007/s10593-023-03165-3
中图分类号
O62 [有机化学];
学科分类号
070303 ; 081704 ;
摘要
In this study, a new tandem method was developed for the synthesis of thiazole-substituted pyrrolo[1,2-d][1,2,4]triazin-4(3H)-one derivatives. The method consists of a tandem reaction involving a subsequent formation of first the thiazole and then the triazine ring upon the addition of phenacyl bromide to a product of the condensation reaction between ethyl 2-formyl-1H-pyrrole- 1-carboxylate and thiosemicarbazide. The tandem cyclization step was completed in just 30 minutes. In order to predict the reaction mechanism, the charge densities of atoms and HOMO and LUMO energy were calculated by DFT method for the compounds obtained in the intermediate stage. In addition, a series of pyrrolotriazinone derivatives synthesized in high yields by this method were found to be suitable drug candidates according to their druglikeness and theoretical pharmacokinetic profiles.
引用
收藏
页码:80 / 87
页数:8
相关论文
共 34 条
[1]  
Beck H, 2022, DRUG DISCOV TODAY, V27, P1560, DOI [10.1016/j.drudis.2022.02.015This, 10.1016/j.drudis.2022.02.015]
[2]  
Cheng FX, 2013, CURR TOP MED CHEM, V13, P1273
[3]   Chemical predictive modelling to improve compound quality [J].
Cumming, John G. ;
Davis, Andrew M. ;
Muresan, Sorel ;
Haeberlein, Markus ;
Chen, Hongming .
NATURE REVIEWS DRUG DISCOVERY, 2013, 12 (12) :948-962
[4]   SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules [J].
Daina, Antoine ;
Michielin, Olivier ;
Zoete, Vincent .
SCIENTIFIC REPORTS, 2017, 7
[5]   Non-basic azolotriazinone MCHR1 antagonists for the treatment of obesity: An empirical brain-exposures-driven candidate selection for in vivo efficacy studies [J].
Devasthale, Pratik ;
Wang, Wei ;
Mignone, James ;
Renduchintala, Kishore ;
Radhakrishnan, Sridhar ;
Dhanapal, Jayanthi ;
Selvaraj, Jagannath ;
Kuppusamy, Rajesh ;
Pelleymounter, Mary Ann ;
Longhi, Daniel ;
Huang, Ning ;
Flynn, Neil ;
Azzara, Anthony V. ;
Rohrbach, Kenneth ;
Devenny, James ;
Rooney, Suzanne ;
Thomas, Michael ;
Godonis, Helen ;
Harvey, Susan ;
Cullen, Mary Jane ;
Zhang, Hongwei ;
Caporuscio, Christian ;
Stetsko, Paul ;
Grubb, Mary ;
Huang, Christine ;
Zhang, Lisa ;
Freeden, Chris ;
Murphy, Brian J. ;
Robl, Jeffrey A. ;
Washburn, William N. .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2015, 25 (20) :4412-4418
[6]  
Frisch M.J., 2016, Gaussian 09, Revision D.01
[7]   Eco-Friendly Synthesis of Some Thiosemicarbazones and Their Applications as Intermediates for 5-Arylazothiazole Disperse Dyes [J].
Gaffer, Hatem E. ;
Khalifa, Mohamed E. .
MOLECULES, 2015, 20 (12) :21982-21991
[8]   Pyrrolotriazinone as an Underexplored Scaffold in Drug Discovery [J].
Ge, Tony ;
Cintrat, Jean-Christophe .
PHARMACEUTICALS, 2021, 14 (12)
[9]   Gold-Catalyzed Oxime-Oxime Rearrangement [J].
Guven, Sinem ;
Ozer, Merve Sinem ;
Kaya, Serdal ;
Menges, Nurettin ;
Balci, Metin .
ORGANIC LETTERS, 2015, 17 (11) :2660-2663
[10]   SYNTHESIS AND REACTIONS OF N-PROTECTED 2-LITHIATED PYRROLES AND INDOLES - THE TERT-BUTOXYCARBONYL SUBSTITUENT AS A PROTECTING GROUP [J].
HASAN, I ;
MARINELLI, ER ;
LIN, LCC ;
FOWLER, FW ;
LEVY, AB .
JOURNAL OF ORGANIC CHEMISTRY, 1981, 46 (01) :157-164